Summary
Vitamin D-binding protein (DBP) concentrations were determined in the sera of 90 cystic fibrosis homozygotes, 57 obligate heterozygotes, and 46 normal controls. Very significantly lower mean concentrations were found in the sera of CF homozygotes compared with both heterozygotes and controls (P<0.01, Wilcoxon Rank Sums Test). Subdivision of the samples by Gc phenotype showed that this relationship held true both in the Gc1 and Gc2-1 phenotypes. The small sample size of the Gc2 genotype makes the significance levels of limited usefulness, but the pattern of variation of DBP levels among CF homozygotes, heterozygotes, and controls was consistent with that observed for the Gc1 and Gc2-1 classes. Haptoglobin levels showed high coefficients of variation when compared among CF homozygotes, obligate heterozygotes, and controls, presumably because of nonspecific elevation in the acute-phase response. Alpha2-macroglobulin levels were, if anything, slightly elevated in CF homozygotes compared with controls, while albumin levels showed no significant mean differences between these groups. Since the DBP concentration does not vary with age nor with levels of vitamin D and its metabolites, we interpret our results to mean that DBP levels are specifically decreased in cystic fibrosis, perhaps as the result of impaired glycosylation of the protein.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alhadeff JA (1978) Glycoproteins and cystic fibrosis: A review. Clin Genet 14:198–201
Allen A, Mantle M, Pearson JP (1980) The structure and properties of mucous glycoproteins. In: Sturgess JM (ed) Perspectives in cystic fibrosis. Imperial Press, Mississauga, Canada, pp 102–112
Barragry JM, Corless D, Auton J, Carter ND, Long RG, Maxwell JD, Switila S (1978) Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy, and chronic liver disease. Clin Chim Acta 87:359–365
Bouillon R, Van Baelen H, DeMoor P (1977) The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab 45:225–231
Brown IRF, Carter ND, Sood A (1979) Vitamin D binding globulin phenotypes in liver disease. Clin Chim Acta 95:75–82
Cleve H (1973) The variants of the group-specific component. Israel J Med Sci 9:1133–1146
Cleve H, Dencker H (1966) Quantitative variations of the group-specific component (Gc) and of Barium-α2-glycoprotein of human serum in health and disease. Protides Biol Fluids 14:379–384
Constans J, Viau M, Cleve H, Jaeger G, Quilici JC, Palisson MJ (1978) Analysis of the Gc polymorphism in human populations by isoelectric focusing on polyacrylamide gels. Hum Genet 41:53–60
Daiger SP, Miller M, Romeo G, Parsons M, Cavalli-Sforza LL (1978) Vitamin D-binding globulin in the Williams syndrome and idiopathic hypercalcemia. N Engl J Med 298:687–688
Fairney A, Fry J, Lipscomb A (1979) The effect of darkness on vitamin D in adulds. Postgrad Med J 55:248–250
Gibbons JD (1976) Nonparametric methods for quantitative analysis. Holt, Rinehart, and Winston, New York
Haddad JG, Walgate J (1976) Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum. J Clin Invest 58:1217–1222
Hahn TJ, Squires AE, Halstead LR, Strominger DB (1979) Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 94:38–42
Hickman S, Kalczycki A, Lynch RG, Kornfeld S (1977) Studies on the mechanism of tunicamycin inhibition of IgA and IgE secretion by plasma cells. J Biol Chem 252:4402–4408
Housley TJ, Rowland FN, Ledger PW, Kaplan J, Tanzer JL (1980) Effects of tunicamycin on the biosynthesis of procollagen by human fibroblasts. J Biol Chem 255:121–128
Hubbard VS, Farrell PM, diSant'Agnese PA (1979) 25-hydroxycholecalciferol levels in patients with cystic fibrosis. J Pediatr 94: 84–86
Imawari M, Goodman DS (1977) Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum. J Clin Invest 59:432–442
Kawakami M, Imawari M, Goodman DS (1979) Quantitative studies of the interaction of cholecalciferol (vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem J 197:413–423
Kitchin FD, Bearn AG (1965) Quantitative determination of the group specific protein in normal human serum. Proc Soc Exptl Med Biol 110:304–307
Koj A (1974) Acute-phase reactants. In: Allison AC (ed) Structure and function of plasma proteins, vol 1. Plenum, New York, pp 73–131
Kueppers F, Harpel B (1979) Group-specific component (Gc) subtypes of Gcl by isoelectric focusing in US blacks and whites. Hum Hered 29:242–249
Kurosky A, Barnett DR, Lee T-H, Touchstone B, Hay RE, Arnott MS, Bowman BH, Fitch W (1980) Covalent structure of human haptoglobin: A serine protease homologue. Proc Natl Acad Sci USA 77: 3388–3392
Lawson DEM, Paul AA, Black AE, Cole TJ, Mandal AR, Davie M (1979) Relative contributions of diet and sunlight to vitamin D state in the elderly. Br Med J 2:303–305
Mancini M, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem 2:235–254
Rostenburg I, Rico R, Penaloza R (1979) Gc globulin and prealbumin serum levels in patients with cancer and benign inflammatory diseases and in asymptomatic smokers. J Natl Cancer Inst 62: 299–300
Schidlow DV, Kueppers F (1980) Trypsin binding activity of alpha2-macroglobulin in cystic fibrosis and other lung diseases. Am Rev Resp Dis 121:31–37
Schultze HF, Heremans JF (1966) Molecular biology of human proteins, Vol 1. Elsevier, Amsterdam, pp 173–235
Shapira E, Ben-Yoseph Y, Nadler HL (1977) Abnormal breakdown of α2-macroglobulin-trypsin complex in cystic fibrosis. Clin Chim Acta 78:359–363
Snedecor GW, Cochran WG (1967) Statistical methods, 6th ed. Iowa State University Press, Ames
Strober W, Peter G, Schwartz RH (1969) Albumin metabolism in cystic fibrosis. Pediatrics 43:416–426
Sutton HE (1970) The haptoglobins. In: Steinberg AG, Bearn AG (eds) Progress in medical genetics, Vol 7. Grune and Stratton, New York, pp 163–216
Svasti J, Bowman BH (1978) Human group-specific component. J Biol Chem 253:4188–4194
Svasti J, Kurosky A, Bennett A, Bowman BH (1979) Molecular basis for the three major forms of human serum vitamin D-binding protein (group-specific component). Biochemistry 18:1611–1617
Valette I, Pointis J, Rondeau Y, Waks M, Engler R (1979) Is immunochemical determination of haptoglobin phenotype dependent? Clin Chim Acta 99:1–6
Weisman Y, Reiter E, Stern RC, Root A (1979) Serum concentrations of 25-hydroxyvitamin D and 24, 25-dihydroxyvitamin D in patients with cystic fibrosis. J Pediatr 94:416–418
Author information
Authors and Affiliations
Additional information
A preliminary report of this work appeared in the Proceedings of the 8th International Congress on Cystic Fibrosis.
Rights and permissions
About this article
Cite this article
Coppenhaver, D., Kueppers, F., Schidlow, D. et al. Serum concentrations of vitamin D-binding protein (Group-specific component) in cystic fibrosis. Hum Genet 57, 399–403 (1981). https://doi.org/10.1007/BF00281693
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00281693